leisure time -WSS

leisure time

author：hotspot 2025-09-30 00:09:23 - browse：2

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug developer, and the sorry state of biotech stocks.

For more on what we cover, here’s the Mojsov story; here’s the latest on BrainStorm; here’s the news on Intercept Pharmaceuticals; here’s more on the biotech market; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： How to save PrEP access — and even expand it
Next article： Reporting on presidential health from Reagan to Trump and Biden

hotspot

WSS

FDA warns medical device makers about rise in fabricated data

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Congress may force more Covid

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Medicare Advantage enrollment hits roughly 33.4 million

Wikipedia

leisure time

focus

At least 13 dead in Texas as scorching temps continue

Medical device trials still don't enroll enough women, study finds

DIEP, the 'gold standard' of breast reconstruction, is under threat

As AI regulations shape up, health tech startups beg for clarity

The high cost of giving birth even with insurance

NIH tests clinical research in primary care with $30 million program

In Memoriam: Notable people who died in 2023

STAT Virtual Event: ASCO Recap, Live!

Moonlake's readout produced a cash windfall. Risks remain

Health care court cases: Humana, Sutter, Novant

Wikipedia

My daughter's legacy lives on through her writing, phage therapy

Teladoc has a new CEO, but challenges remain the same

California wildfire smoke linked to 52,000 early deaths, study says

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Surprise medical billing ban raises prices elsewhere

Abridge raises $150m as clinical notes automation market heats up

knowledge

hotspot

explore

hotspot